Category Archives: Parkinson’s Treatment

-- Company stops further development of clinically symptomatic respiratory illness indication but continues development of RTB101 in other aging-related diseases, including Parkinsons disease -- -- Company remains well funded with $117.3 million in cash, cash equivalents and marketable securities as ofSeptember 30, 2019 -- -- Management to host conference call at 8:00 a.m. EST today -- BOSTON, Nov. 15, 2019 (GLOBE NEWSWIRE) -- resTORbio, Inc., (Nasdaq: TORC), a clinical-stage biopharmaceutical company developing innovative medicines that target the biology of aging to prevent or treat aging-related diseases, today announced that top line data from the PROTECTOR 1 Phase 3 study, evaluating the safety and efficacy of RTB101 in preventing clinically symptomatic respiratory illness (CSRI) in adults age 65 and older, did not meet its primary endpoint, and that it has stopped the development of RTB101 in this indication Continue reading →

IOWA CITY, Iowa (KWWL) Dottie Armens was diagnosed with Parkinsons in 2007 and now leads a support group in Iowa City for others fighting the disease. Continue reading →

When you are new to something, its common to feel disconnected or out of place especially when it comes to understanding the language. Continue reading →

West Virginia University researchers are exploring whether deep brain stimulation can help patients with opioid use disorder who haven't responded to other types of treatment. The clinical trial the first of its kind in the United States comes as opioid addiction remains a major health crisis throughout the U.S. About 130 Americans die each day from an opioid overdose, according to theU.S Continue reading →

KINGSTON A University of Rhode Island professor has been awarded a $249,977 federal grant because a smart glove he is developing to help patients with Parkinsons disease has the potential for commercial success and societal impact. The glove, which can collect data based on the movements of those living with Parkinsons disease and other movement disorders, is being developed by University of Rhode Island Associate Professor of Engineering Kunal Mankodiya. Such technology could be of significant help to the hundreds of thousands with the disease in this country Continue reading →

Opened Enrollment of PROPEL Phase 1/2 Trial of PR001 to Treat Parkinsons Disease Patients with GBA1 Mutations PR001 for Neuronopathic Gaucher Disease and PR006 for Frontotemporal Dementia with GRN Mutations Progressing Towards Clinic Ongoing Collaboration with Lonza to Support the Manufacturing of our Pipeline of Novel AAV9-Based Gene Therapy Programs NEW YORK, Nov. 12, 2019 (GLOBE NEWSWIRE) -- Prevail Therapeutics Inc. Continue reading →

Anne Pelletier-Cameron, M.D., often jokes to her patients that shes a female plumber of the lower urinary tract. On a more professional note, however, shes a urologist in the Michigan Medicine Department of Urology. In this role, Pelletier-Cameron treats patients with a variety of lower urinary tract symptoms Continue reading →

Parkinsons UK and Alzheimers Research UK have teamed up to help fund a project that will test whether a waste disposal system in the brain could be exploited to help in the understanding and treatment of these diseases, Parkinsons UK announced. The new project, which is expected to take about three years to complete, will focus specifically on the glymphatic system. This system, which was discovered only recently, helps to remove waste products from the brain. Continue reading →

Most people with Gaucher disease (GD) would like to be informed by their health care provider at diagnosis of their risk of developing Parkinsons disease, a survey among U.S. patients shows Continue reading →

Whether its the smell of cookies baking or Fidos ahem gas, smells have a way of seizing our attention. But when subtle odors interfere with daily living, you may have a condition called hyperosmia. Cleveland Clinic is a non-profit academic medical center Continue reading →